) ACQUITY UPLC TQD system has been approved as a medical device by
the Chinese Food and Drug Administration and can now be legally
promoted and sold in China. This device will primarily be used for
regular diagnostic applications and neonatal metabolites disease
(Ultra Performance Liquid Chromatography/ tandem quadrupole mass
spectrometry UPLC/MS/MS system)is an ultra-compact,
tandem-quadrupole, mass detector-based system designed for routine
UPLC/MS/MS analyses and quantitative applications featuring high
levels of MS selectivity, robustness, speed, and accuracy.
The approval of ACQUITY UPLC is important for Waters as well as
China. Notably, this marks the second medical device approval for
Waters, the first being a neonatal screening solution which
included the Waters Quattro micro mass spectrometer. On the other
hand, both Chinese citizens and analytical scientists and
laboratories will benefit from this sanction.
Waters Corporation is a leading analytical instrument
manufacturer that designs, manufactures and sells high performance
liquid chromatography (LC) and mass spectrometry (MS) instrument
systems and support products, including chromatography columns,
other consumable products and comprehensive post-warranty service
Waters has a strong presence in the chromatography instrument
industry and is currently one of the top three players in the mass
spectrometry market. The company is expected to sustain its healthy
organic sales growth over the next few years based on strong
customer demand in the mass spectrometry and High Performance and
Ultra Performance Liquid Chromatography markets.
Waters currently has a Zacks Rank #3 (Hold). Some better-ranked
companies in the sector include
Mettler-Toledo International Inc
). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
WATERS CORP (WAT): Free Stock Analysis Report
PERKINELMER INC (PKI): Free Stock Analysis
AROTECH CORP (ARTX): Get Free Report
METTLER-TOLEDO (MTD): Free Stock Analysis
To read this article on Zacks.com click here.